TIL Therapy Optimized for Tumor Reactive T-Cell Selection

Time: 10:30 am
day: Conference Day 1

Details:

  • Explore neoantigen identification approaches to achieve patient specific TIL therapy
  • Next generation approaches to improve TIL quality, especially in colder tumors

Speakers: